Brain single photon emission computed tomography: Technological aspects and clinical applications

Seminars in Neurology

Volumn 28, Issue 4, 2008, Pages 423-434

  Masdeu, Joseph C ^a   Arbizu, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Brain; Brain diseases; Neuroimaging; Single photon emission computed tomography

Indexed keywords

ACETAZOLAMIDE; ACICLOVIR; ALPHA METHYLTYROSINE I 123; BETA CARBOMETHOXY 3 BETA (4 IODOPHENYL)TROPANE I 123; CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODOBENZAMIDE I 123; IOFLUPANE I 123; ISOPROPYLIODOAMPHETAMINE I 123; RADIOACTIVE MATERIAL; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; STREPTOKINASE; THALLIUM 201; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE; XENON 133;

AIDS RELATED COMPLEX; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN ABSCESS; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN DEATH; BRAIN DISEASE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN TOMOGRAPHY; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG DISTRIBUTION; DRUG UPTAKE; EPILEPSY; EXTRAPYRAMIDAL SYNDROME; FIBRINOLYTIC THERAPY; FOURIER TRANSFORMATION; HEAD INJURY; HERPES SIMPLEX ENCEPHALITIS; HUMAN; INTERMETHOD COMPARISON; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STENOSIS; STROKE; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

BRAIN; BRAIN DISEASES; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 56049113060     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0028-1083683     Document Type: Review

References (62)

1. Catafau AM. Brain SPECT in clinical practice. Part I: perfusion. J Nucl Med 2001;42:259-271
2. Devous MD. Single-photon emission computed tomography in neurotherapeutics. NeuroRx 2005;2:237-249
3. Vastenhouw B, Beekman F. Submillimeter total-body murine imaging with U-SPECT-I. J Nucl Med 2007;48:487-493
4. Wintermark M, Sesay M, Barbier E, et al. Comparative overview of brain perfusion imaging techniques. J Neuroradiol 2005;32:294-314
5. Seibyl J, Jennings D, Tabamo R, Marek K. Unique roles of SPECT brain imaging in clinical and research studies. Lessons from Parkinson's disease research. Q J Nucl Med Mol Imaging 2005;49:215-221
6. Catafau AM, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 2004;19:1175-1182
7. Masdeu JC. Imaging of stroke with SPECT. In: Babikian V, Wechsler L, Higashida RT, eds. Imaging Cerebrovascular Disease. Boston, MA: Butterworth-Heinemann; 2003:131-144
8. 99mTc- hexamethylpropylene amine oxime single-photon emission computed tomography. Ann Neurol 1993;33:43-47
9. Lewis DH, Longstreth W Jr, Wilkus R, Copass M. Hyperemic receptive aphasia on neuroSPECT. Clin Nucl Med 1993;18:409-412
10. Matsumoto K, Awata S, Matsuoka H, Nakamura S, Sato M. Chronological changes in brain MRI, SPECT, and EEG in neurosarcoidosis with stroke-like episodes. Psychiatry Clin Neurosci 1998;52:629-633
11. Berrouschot J, Barthel H, Hesse S, Koster J, Knapp WH, Schneider D. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD-SPECT. J Cereb Blood Flow Metab 1998;18:921-929
12. Laloux P, Jamart J, Meurisse H, De-Coster P, Laterre C. Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup?. Stroke 1996;27:425-430
13. Nuutinen J, Kuikka J, Roivainen R, Vanninen E, Sivenius J. Early serial SPECT in acute middle cerebral artery infarction. Nucl Med Commun 2000;21:425-429
14. Barthel H, Hesse S, Dannenberg C, et al. Prospective value of perfusion and x-ray attenuation imaging with single-photon emission and transmission computed tomography in acute cerebral ischemia. Stroke 2001;32:1588-1597
15. Mahagne MH, Darcourt J, Migneco O, et al. Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery. Cerebrovasc Dis 2000;10:364-373
16. Baird AE, Austin MC, McKay WJ, Donnan GA. Sensitivity and specificity of 99mTc-HMPAOSPECT cerebral perfusion measurements during the first 48 hours for the localization of cerebral infarction. Stroke 1997;28:976-980
17. Brass LM, Walovitch RC, Joseph JL, et al. The role of single photon emission computed tomography brain imaging with 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke. J Cereb Blood Flow Metab 1994;14:S91-S98
18. Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998;29:2556-2562
19. Alexandrov AV, Black SE, Ehrlich LE, et al. Simple visual analysis of brain perfusion on HMPAO SPECT predicts early outcome in acute stroke. Stroke 1996;27:1537-1542
20. Hirano T, Read SJ, Abbott DF, et al. Prediction of the final infarct volumewithin 6 h of stroke using single photon emission computed tomography with technetium-99m hexamethylpropylene amine oxime. Cerebrovasc Dis 2001;11:119-127
21. Alexandrov AV, Masdeu JC, Devous MSr, Black SE, Grotta JC. Brain single-photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemic stroke. Proceedings of the meeting of the SPECT Safe Thrombolysis Study Collaborators and the members of the Brain Imaging Council of the Society of Nuclear Medicine. Stroke 1997;28:1830-1834
22. Baron JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001;11:2-8
23. Karonen JO, Vanninen RL, Liu Y, et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. Stroke 1999;30:1583-1590
24. Liu Y, Karonen JO, Vanninen RL, et al. Cerebral hemodynamics in human acute ischemic stroke: a study with diffusion- and perfusion-weighted magnetic resonance imaging and SPECT. J Cereb Blood Flow Metab 2000;20:910-920
25. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000;20:1276-1293
26. Ogasawara K, Ogawa A, Ezura M, et al. Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT. J Nucl Med 2001;42:543-547
27. Ogasawara K, Ogawa A, Ezura M, Konno H, Suzuki M, Yoshimoto T. Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion. AJNR Am J Neuroradiol 2001;22:48-53
28. Ryu YH, Chung TS, Yoon PH, et al. Evaluation of reperfusion and recovery of brain function before and after intracarotid arterial urokinase therapy in acute cerebral infarction with brain SPECT. Clin Nucl Med 1999;24:566-571
29. Ueda T, Sakaki S, Yuh WT, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999;19:99-108
30. Sasaki O, Takeuchi S, Koizumi T, Koike T, Tanaka R. Complete recanalization via fibrinolytic therapy can reduce the number of ischemic territories that progress to infarction. AJNR Am J Neuroradiol 1996;17:1661-1668
31. Grotta JC, Alexandrov AV. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke 1998;29:429-432
32. Berrouschot J, Barthel H, Hesse S, Knapp WH, Schneider D, von Kummer R. Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischemic stroke and thrombolytic therapy. Stroke 2000;31:1545-1551
33. Nakano S, Iseda T, Ikeda T, Yoneyama T, Wakisaka S. Thresholds of ischemia salvageable with intravenous tissue plasminogen activator therapy: evaluation with cerebral blood flow single-photon emission computed tomographic measurements. Neurosurgery 2000;47:68-71; discussion 71-63
34. Umemura A, Suzuka T, Yamada K. Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options. J Neurol Neurosurg Psychiatry 2000;69:472-478
35. Yasaka M, O'Keefe GJ, Chambers BR, et al. Streptokinase in acute stroke: effect on reperfusion and recanalization. Australian Streptokinase Trial Study Group. Neurology 1998;50:626-632
36. Rossler A, Berrouschot J, Barthel H, Hesse S, Koster J, Schneider D. Potential of rheopheresis for the treatment of acute ischemic stroke when initiated between 6 and 12 hours. Ther Apher 2000;4:358-362
37. Berrouschot J, Barthel H, Koster J, et al. Extracorporeal rheopheresis in the treatment of acute ischemic stroke: a randomized pilot study. Stroke 1999;30:787-792
38. Kita T, Hayashi K, Yamamoto M, et al. Does supplementation of contrast MR imaging with thallium-201 brain SPECT improve differentiation between benign and malignant ring-like contrast-enhanced cerebral lesions? Ann Nucl Med 2007;21:251-256
39. Vallejos V, Balana C, Fraile M, et al. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas. J Neurooncol 2002;59:81-90
40. Plotkin M, Amthauer H, Eisenacher J, et al. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours. Neuroradiology 2005;47:18-26
41. Tucker KA, Robertson KR, Lin W, et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol 2004;157:153-162
42. Masdeu JC, Van Heertum RL, Abdel-Dayem H. Viral infections of the brain. J Neuroimaging 1995;5(suppl 1):S40-S44
43. O'Malley JP, Ziessman HA, Kumar PN, Harkness BA, Tall JG, Pierce PF. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201TI single-photon emission computed tomography. AJR Am J Roentgenol 1994;163:417-421
44. Ruiz A, Ganz WI, Post MJ, et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR Am J Neuroradiol 1994;15:1885-1894
45. Giancola ML, Rizzi EB, Schiavo R, et al. Reduced value of thallium-201 single-photon emission computed tomography in the management of HIV-related focal brain lesions in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2004;20:584-588
46. Licho R, Litofsky NS, Senitko M, George M. Inaccuracy of Tl-201 brain SPECT in distinguishing cerebral infections from lymphoma in patients with AIDS. Clin Nucl Med 2002;27:81-86
47. Kim DG, Lee JI, Lee DS, Lee MC, Choi KS, Han DH. 99mTc-HMPAO labeled leukocyte SPECT in intracranial lesions. Surg Neurol 1995;44:338-345
48. Masdeu JC, Abdel-Dayem H, Van Heertum RL. Head trauma: use of SPECT. J Neuroimaging 1995;5(suppl 1):S53-S57
49. Lee B, Newberg A. Neuroimaging in traumatic brain imaging. NeuroRx 2005;2:372-383
50. Cascino GD, So EL, Buchhalter JR, Mullan BP. The current place of single photon emission computed tomography in epilepsy evaluations. Neuroimaging Clin N Am 2004;14:553-561
51. Ho SS, Berkovic SF, Berlangieri SU, et al. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol 1995;37:738-745
52. Masdeu JC, Zubieta JL, Arbizu J. Neuroimaging as a marker of the onset and progression of Alzheimer's disease. J Neurol Sci 2005;236:55-64
53. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571
54. Jagust W, Thisted R, Devous MD Sr, et al. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology 2001;56:950-956
55. Johnson KA, Lopera F, Jones K, et al. Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology 2001;56:1545-1551
56. Walker Z, Costa DC, Walker RW, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73:134-140
57. O'Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004;61:919-925
58. Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005;64:208-215
59. Brooks DJ. PET and SPECT in CNS drug development. NeuroRx 2005;2:226-236
60. Masdeu JC, Bakshi R. Neuroimaging: anything to do with neurotherapeutics? NeuroRx 2005;2:163-166
61. Eckert T, Eidelberg D. Neuroimaging and therapeutics in movement disorders. NeuroRx 2005;2:361-371
62. Facco E, Zucchetta P, Munari M, et al. 99mTc-HMPAO SPECT in the diagnosis of brain death. Intensive Care Med 1998;24:911-917